Beta Sitosterol Prostate Treatment for Benign Prostatic Hyperplasia (BPH)
Prostate Cancer: A Silent Killer of Men
This last summer, I had the somber experience of attending the funeral of a friend who passed away far too young. He was only 64. Taking the life of this intelligent, warm, faithful father of two boys, and loyal husband to his only wife of over 30 years, was prostate cancer.
“Rich” (as I’ll refer to him) was initially diagnosed with this silent killer of men in his early 40s, which is the age-range most medical professionals tell males to begin annual (or even bi-annual) prostate exams. I’m 41 and I’m due for my next screening soon. Men, do not procrastinate with your prostate!
Statistics from the National Cancer Institute, reported in 2008, reveal 510 new prostate cancer diagnoses every single day—resulting in 78 deaths per day. For men, those are scary numbers. In light of these statistics, I feel it’s safe to assume men need to take this condition seriously. The encouraging news is that if detected early, prostate cancer enjoys a 90% cure rate. For men, those are great numbers!
The bottom line (pardon the pun) is this. With early detection, a healthy diet, and eliminating other risk factors such as smoking and excessive alcohol intake, prostate cancer can be conquered. I encourage all my fellow men to take heed.
Benign Prostatic Hyperplasia: Commonly known as BPH
Common statistics reveal that by age 50, the majority of men typically begin developing some symptoms associated with BPH. Aside from prostate cancer, BPH is defined as a non-cancerous enlargement of the prostate. If you talk to most medical professionals; esp. those specializing in men’s health issues, they will tell you that a huge misconception exists between prostate cancer and BPH. The fact is this: the presence of BPH (according to known research) does not increase the chances of developing prostate cancer. Most certainly, though, if you are experiencing any BPH symptoms, you should always have them checked out by a qualified medical professional. A short list of these symptoms includes:
- Difficulty in urinating
- Weak flow during urinating
- A feeling of not feeling empty after urinating
- A sudden and often uncontrollable urge to urinate
- Frequent urination
- Waking at night to urinate (nocturia)
The actual causes of BPH have yet to be discovered but there are known studies and research that has led to a few potential causes. The number one reason BPH develops is age. The prostate gland during its lifespan goes through two stages of growth. Stage one occurs at puberty as young men begin to mature sexually, while stage two takes place after the age of 25. This second stage, brought on by a reactivation of DHT (dihydrotestosterone) continues for the remainder of a man’s life and is a likely cause for BPH. This reactivation of DHT is the result of decreasing testosterone levels in men as age progresses.
Whatever the cause may be, the symptoms of BPH are uncomfortable and inconvenient. There is, however, a ray of hope shining in the form of an all-natural prostate treatment known as beta sitosterol.
Beta Sitosterol: Highly Effective Against BPH
Research has shown this powerful plant extract to be highly-effective in its ability to not only improve the symptoms of BPH, such as weak urinary flow, frequent urination, a feeling of not being empty, and urgency but possibly reduce the risk of prostate cancer as well.
Highly Effective BPH Treatment
Whenever talk of a seemingly successful treatment for BPH (or any other condition for that matter) arises, it’s the proof and validity of the research and subsequent results that eventually hold weight. And not surprisingly to many people, beta sitosterol is proving its effectiveness; esp. when compared to other often-promoted prostate supplements such as Saw Palmetto and Nettle Root. In fact, beta sitosterol has been found to be over 3,000 (yes, 3,000) times more effective in reducing BPH symptoms than the afore-mentioned products.
Here are some documented, multi-study results.
In prostate studies, the International Prostate Symptom Score (IPSS) is a well-accepted standard for calculating results. The IPSS scale is a number from 0-35 that takes into account all prostate symptoms (including quality of life) and weighs them for an overall score. And similar to golf, lower scores are better.
According to a 1993, double-blind, double-placebo European study, beta sitosterol supplementation among a group of 200 men for 6 months lowered the IPSS score by 7.4 points; which was 3.5 times greater when compared to the placebo.
Also included in this study, beta stosterol was proven to increase maximum urinary flow rate (QMAX) by 35% and reduce post-voided residual urine (PVR) by 54%. – Now to me, those are substantial findings; findings that should raise serious consideration of the strength and validity of beta sitosterol as an effective treatment for BPH.
Beta Sitosterol and Prostate Cancer
Aside from its powerful benefits for controlling BPH, beta sitosterol has been documented in highly respected studies, i.e., (Fortschitte Med., vol. 98) to inhibit the growth of prostate tumors while reducing the prostaglandins known to support tumor growth.
Although not yet completely proven to defeat prostate cancer, beta sitosterol has been found to combat the growth of prostate cancer cells by up to 25% while also increasing the programmed death cell rate (those cells most susceptible to malignancy) at a rate four times that of other supplements. Incredible!
Many of the findings regarding beta sitosterol are solid and convincing, but there is still a lot of research to be done. What we do know, however, is that beta sitosterol may very well be the next great advancement in BPH treatment and prostate cancer prevention and curtailment. I would suggest you do your own research and conclude for yourself.
Don't be silently led away.
- (Kirby RS, Christmas TJ. Benign Prostate Hyperplasia. London, England: Mosby-Year Book Europe Limited; 1993) Zahradnit, et al, in Fortschritte Med., vol. 98, p. 69-72 (1980)
- Beta-Sitosterol activates the sphingomyelin cycle and induces apoptosis in LNCaP human prostate cancer cells. Author: von Holtz RL; Fink CS; Awad AB Address: Department of Physical Therapy, Exercise, and Nutrition Sciences, State University of New York at Buffalo 14214-3000, USA Source: Nutr Cancer, 32(1):8-12 1998
- Randomized, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group. Author: Berges RR; Windeler J; Trampisch HJ; Senge T Address: Department of Urology, Ruhr-University, Bochum, Germany. Source: Lancet, 345(8964):1529-32 1995 Jun 17
- A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study group. Author: Klippel KF; Hiltl DM; Schipp B Address: Department of Urology, Allgemeines Krankenhaus Celle, Academic Hospital, Germany. Source: Br J Urol, 80(3):427-32 1997 Sep